Citigroup analyst Vikram Bagri maintains NuScale Power (NYSE:SMR) with a Sell and lowers the price target from $4 to $3.5.
Investing.com -- TeraWulf (WULF) beat on both lines in Q3 2026, reported Nov 6. The stock still gave back most of its early gain. It rose as much as +...
Atlassian beat estimates and raised its yearly outlook, yet investors dumped the stock the moment the numbers landed. One forecast number spooked the ...
Humana's Star rating gains and new BlackRock partnership shape its 2027 margin outlook.
2026-11-06. The following slide deck was published by Array Technologies, Inc.
Calumet stock surged after a Q3 earnings beat, strong Specialty Products demand, and Montana Renewables upside. Click to read this outlook on the CLMT...
2026-11-06. The following slide deck was published by Deutsche Lufthansa AG in conjunction with their 2026 Q3 earnings call.
Citigroup analyst Tyler Radke maintains HubSpot (NYSE:HUBS) with a Neutral and lowers the price target from $287 to $230.
The retailer is testing a new way for U.S. customers to find products, compare prices and complete purchases.
Wholesale gains offset softer retail fuel volumes in a strong quarter.
Record cash flow offset by rising input costs and a sharply lower outlook
Capital recycling and AI expansion drove a 10% funds-from-operations gain.
The total number of active drilling rigs for oil and gas in the United States rose slightly this week
Key TakeawaysQualcomm shares rose 5% today on Alphabet’s nearly $548 million stake. The stake backs Qualcomm’s data center push, still targeting $5 bi...
Riley Exploration Permian’s modeled fair value has shifted from US$46 to US$56, establishing a higher reference point for where analysts see the stock...
Citigroup analyst Tyler Radke maintains Figma (NYSE:FIG) with a Buy and lowers the price target from $35 to $34.
Moby summary of Atmus Filtration Technologies Inc.'s Q3 2026 earnings call
Oklo’s modeled fair value price target has been cut from US$73.00 to US$65.25, a decline of about 10.6% that reflects the latest reset in analyst expe...
2026-11-06. The following slide deck was published by Dana Incorporated in conjunction with this event.
Castle Biosciences reported third quarter 2026 revenue of US$102.89 million compared with US$83.04 million a year earlier, with a quarterly net loss o...
Loading...
